维普期刊资源整合服务平台（V6.5）

120篇 您的检索式：作者名="Carter HB"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?显示文摘	Carter HB Epstein JI	2003	J Urol2003，170，6：	1
2	Metabolic factors associated with benign prostatic hyperplasia 显示文摘	Parsons JK Carter HB Partin AW	2006	J Clin Endocri- nol Metab2006，91，7：	1
3	Metabolic factors associat- ed with benign prostatic hyperplasia 显示文摘	Parsons JK Carter HB Partin AW	2006	J Clin Endocrinol Metab2006，91，7：	1
4	Early detection of prostate cancer in 2007-part 1:PSA and PSA kinetics显示文摘	Schrder FH Carter HB Wolters T	2008	European Urology2008，53，3：	1
5	The use of prostate specificantigen,clinical stage anf Gleason score to predict pathologicalstage in men with localized prostate cancer显示文摘	Partin AW Yoo J Carter HB	1993	J Urol1993，150，1：	1
6	Prostate-specific antigen velocity and repeated measures of prostate-specific antigen显示文摘	Carter HB Pearson JD	1997	Urol Clin North Am1997，24，2：	1
7	Early detection of prostate cancer: AUA Guideline 显示文摘	Carter HB Albertsen PC Barry MJ	2013	Urol2013，5347，13：	1
8	Longitudinal evaluation ofprostate-spescific antigen levels in men with and without prostate disease显示文摘	Carter HB Pearson JD Metter EJ	1992	JAMA1992，267，16：	1
9	Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease显示文摘	Carter HB Pearson JD Metter E J	1992	J AMA1992，267，：	1
10	Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease显示文摘	Carter HB Morrell CH Pearson JD	1992	Cancer Res1992，52，12：	1
11	Metabolic factors associated with benign prostat ichyperplasia显示文摘	Parsons JK Carter HB Partin AW	2006	J Clin Endocrinol Metab2006，91，7：	1
12	Metabolite factors as- sociated with benign prostate hyperplasia 显示文摘	Parsons JK Carter HB Partin AW	2006	J Clin Endoerinol Metab2006，91，7：	1
13	Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease显示文摘	Carter HB Pearson JD Metter EJ et el	1992	JAMA1992，267，：	1
14	Metabolic factors associated withbenign prostatic hyperplasia显示文摘	Parsons JK Carter HB Partin AW		0，，07：	1
15	Magnetic resonance-invisibleversus magnetic resonance-visible prostate cancer in activesurveillance: a preliminary report on disease outcomes显示文摘	Dianat SS Carter HB Pienta KJ	2015	Urology2015，85，1：	1
16	A Comparision of somatotype methods显示文摘	Heath HB Carter JEL	1966	Am Phys Anthrop1966，24，：	1
17	Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease显示文摘	Carter HB Pearson JD Metter EJ		0，，：	1
18	Multiparametric magnetic resonance imaging(MRI) and active surveillance for prostate cancer: future directions显示文摘	Mullins JK Carter HB	2014	BJU Int2014，113，6：	1
19	Estimation of prostate growth using prostate-specific antigen measurements in men with and without prostate disease显示文摘	Carter HB Morrel CH Pearson JD	1992	CancerRes1992，52，12：	1
20	Expectant man agement of nonpalpable prostate cancer with curative intent:preliminary results显示文摘	Carter HB Walsh PC Landis P	2002	J Urol2002，167，：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示